Psoriasis Trials in Nagoya, Japan
Conditions / Psoriasis / Nagoya, Japan
Clinical trials for Psoriasis investigate a range of treatment strategies and patient populations.
18 total trials for this combination
Showing top 10 of 18 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03624127 | Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis | COMPLETED | PHASE3 |
| NCT05044234 | A Study to Assess Adverse Events and Disease Activity With Cedirogant (ABBV-157) in Adult Participants With Moderate to Severe Psoriasis | TERMINATED | PHASE2 |
| NCT04036435 | Long-Term Study That Measures the Safety and Efficacy of Deucravacitinib (BMS-986165) in Participants With Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT03047395 | A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS ) | COMPLETED | PHASE3 |
| NCT04862286 | Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977 | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT02931838 | Study to Evaluate Effectiveness and Safety in Subjects With Moderate to Severe Psoriasis | COMPLETED | PHASE2 |
| NCT04435600 | A Study of Subcutaneous Risankizumab Injection for Pediatric Participants With Moderate to Severe Plaque Psoriasis to Assess Change in Disease Symptoms | COMPLETED | PHASE3 |
| NCT03535194 | A Study to Assess if Mirikizumab is Effective and Safe Compared to Secukinumab and Placebo in Moderate to Severe Plaque Psoriasis (OASIS-2) | COMPLETED | PHASE3 |
| NCT03556202 | A Long-term Study to Evaluate Safety and Maintenance of Treatment Effect of LY3074828 in Participants With Moderate-to-Severe Plaque Psoriasis (OASIS-3) | TERMINATED | PHASE3 |
| NCT06846541 | Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis | ACTIVE_NOT_RECRUITING | PHASE3 |